Element Capital Management’s Orthofix Medical OFIX Stock Holding History

Element Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,978	Closed	-$230K	–	818
2018 Q3	$230K	Buy	3,978 +231	+6%	+$12.9K	﹤0.01%	706
2018 Q2	$213K	Buy	+3,747	New	+$213K	0.01%	692

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Element Capital Management's OFIX Position: Q4 2018 in Review

Element Capital Management sold out of Orthofix Medical (OFIX) in Q4 2018, closing a stake of 3,978 shares — an estimated $230K sold.

Element Capital Management first reported a position in OFIX in Q2 2018 and held it in 2 quarters. The position peaked at $230K in Q3 2018. 171 funds tracked by Wall St. Rank hold OFIX as of Q4 2018.

Element Capital Management reported no remaining Orthofix Medical position as of Q4 2018 after selling out during the quarter.
Element Capital Management sold 3,978 Orthofix Medical shares in Q4 2018, an estimated $230K.
Element Capital Management first reported a position in Orthofix Medical in Q2 2018 and held it in 2 quarters.
Element Capital Management's Orthofix Medical position peaked at $230K in Q3 2018.
171 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2018.

Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.